In a recent study, epitope spreading was demonstrated to increase the efficiency of the immune checkpoint inhibitor anti-programmed cell death protein-1 (PD-1) in antitumor therapies in patients with melanoma [117]. This evidence concerns the gene PDCD1 and melanoma.